Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A
Copyright © 2021 Elsevier Inc. All rights reserved..
OBJECTIVES: To evaluate the applicability and compliance with guidelines for early initiation of long-term prophylaxis in infants with severe hemophilia A and to identify factors associated with guideline compliance.
STUDY DESIGN: This real-world, prospective, multicenter, population-based FranceCoag study included almost all French boys with severe hemophilia A, born between 2000 and 2009 (ie, after guideline implementation).
RESULTS: We included 333 boys in the study cohort. The cumulative incidence of long-term prophylaxis use was 61.2% at 3 years of age vs 9.5% in a historical cohort of 39 boys born in 1996 (ie, before guideline implementation). The guidelines were not applicable in 23.1% of patients due to an early intracranial bleeding or inhibitor development. Long-term prophylaxis was delayed in 10.8% of patients. In the multivariate analysis, 2 variables were significantly associated with "timely long-term prophylaxis" as compared with "delayed long-term prophylaxis": hemophilia treating center location in the southern regions of France (OR 23.6, 95% CI 1.9-286.7, P = .013 vs Paris area) and older age at long-term prophylaxis indication (OR 7.2 for each additional year, 95% CI 1.2-43.2, P = .031). Long-term prophylaxis anticipation was observed in 39.0% of patients. Earlier birth year (OR 0.5, 95% CI 0.3-0.8, P = .010 for birth years 2005-2009 vs 2000-2004) and age at first factor replacement (OR 1.9 for each additional year, 95% CI 1.2-3.0, P = .005) were significantly associated with "long-term prophylaxis guideline compliance" vs "long-term prophylaxis anticipation.".
CONCLUSIONS: This study suggests that long-term prophylaxis guidelines are associated with increased long-term prophylaxis use. However, early initiation of long-term prophylaxis remains a challenge.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:234 |
|---|---|
| Enthalten in: |
The Journal of pediatrics - 234(2021) vom: 05. Juli, Seite 212-219.e3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Saultier, Paul [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Coagulation Factors |
|---|
| Anmerkungen: |
Date Completed 19.11.2021 Date Revised 19.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jpeds.2021.02.071 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32234185X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32234185X | ||
| 003 | DE-627 | ||
| 005 | 20231225181834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jpeds.2021.02.071 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1074.xml |
| 035 | |a (DE-627)NLM32234185X | ||
| 035 | |a (NLM)33676933 | ||
| 035 | |a (PII)S0022-3476(21)00210-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Saultier, Paul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.11.2021 | ||
| 500 | |a Date Revised 19.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVES: To evaluate the applicability and compliance with guidelines for early initiation of long-term prophylaxis in infants with severe hemophilia A and to identify factors associated with guideline compliance | ||
| 520 | |a STUDY DESIGN: This real-world, prospective, multicenter, population-based FranceCoag study included almost all French boys with severe hemophilia A, born between 2000 and 2009 (ie, after guideline implementation) | ||
| 520 | |a RESULTS: We included 333 boys in the study cohort. The cumulative incidence of long-term prophylaxis use was 61.2% at 3 years of age vs 9.5% in a historical cohort of 39 boys born in 1996 (ie, before guideline implementation). The guidelines were not applicable in 23.1% of patients due to an early intracranial bleeding or inhibitor development. Long-term prophylaxis was delayed in 10.8% of patients. In the multivariate analysis, 2 variables were significantly associated with "timely long-term prophylaxis" as compared with "delayed long-term prophylaxis": hemophilia treating center location in the southern regions of France (OR 23.6, 95% CI 1.9-286.7, P = .013 vs Paris area) and older age at long-term prophylaxis indication (OR 7.2 for each additional year, 95% CI 1.2-43.2, P = .031). Long-term prophylaxis anticipation was observed in 39.0% of patients. Earlier birth year (OR 0.5, 95% CI 0.3-0.8, P = .010 for birth years 2005-2009 vs 2000-2004) and age at first factor replacement (OR 1.9 for each additional year, 95% CI 1.2-3.0, P = .005) were significantly associated with "long-term prophylaxis guideline compliance" vs "long-term prophylaxis anticipation." | ||
| 520 | |a CONCLUSIONS: This study suggests that long-term prophylaxis guidelines are associated with increased long-term prophylaxis use. However, early initiation of long-term prophylaxis remains a challenge | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 7 | |a Blood Coagulation Factors |2 NLM | |
| 700 | 1 | |a Guillaume, Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Demiguel, Virginie |e verfasserin |4 aut | |
| 700 | 1 | |a Berger, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Borel-Derlon, Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Claeyssens, Ségolène |e verfasserin |4 aut | |
| 700 | 1 | |a Harroche, Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Oudot, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Rafowicz, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Trossaert, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Wibaut, Bénédicte |e verfasserin |4 aut | |
| 700 | 1 | |a Vinciguerra, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Boucekine, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Baumstarck, Karine |e verfasserin |4 aut | |
| 700 | 1 | |a Meunier, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Calvez, Thierry |e verfasserin |4 aut | |
| 700 | 1 | |a Chambost, Hervé |e verfasserin |4 aut | |
| 700 | 0 | |a FranceCoag PUPs / CoMETH Prophylaxis Study Group |e verfasserin |4 aut | |
| 700 | 0 | |a Hemophilia Treatment Centers of Paris-Necker |e verfasserin |4 aut | |
| 700 | 1 | |a Aouba, Achille |e investigator |4 oth | |
| 700 | 1 | |a Harroche, Annie |e investigator |4 oth | |
| 700 | 1 | |a Legrand, Faezeh |e investigator |4 oth | |
| 700 | 1 | |a Rothschild, Chantal |e investigator |4 oth | |
| 700 | 1 | |a Torchet, Marie-Françoise |e investigator |4 oth | |
| 700 | 1 | |a d'Oiron, Roseline |e investigator |4 oth | |
| 700 | 1 | |a Lambert, Thierry |e investigator |4 oth | |
| 700 | 1 | |a Laurian, Yves |e investigator |4 oth | |
| 700 | 1 | |a Rafowicz, Anne |e investigator |4 oth | |
| 700 | 1 | |a Biernat, Jennifer |e investigator |4 oth | |
| 700 | 1 | |a Goudemand, Jenny |e investigator |4 oth | |
| 700 | 1 | |a Parquet, Armelle |e investigator |4 oth | |
| 700 | 1 | |a Tintillier, Véronique |e investigator |4 oth | |
| 700 | 1 | |a Wibaut, Bénédicte |e investigator |4 oth | |
| 700 | 1 | |a Assollant, Anne Durin |e investigator |4 oth | |
| 700 | 1 | |a Meunier, Sandrine |e investigator |4 oth | |
| 700 | 1 | |a Négrier, Claude |e investigator |4 oth | |
| 700 | 1 | |a Castet, Sabine |e investigator |4 oth | |
| 700 | 1 | |a Guérin, Viviane |e investigator |4 oth | |
| 700 | 1 | |a Huguenin, Yohann |e investigator |4 oth | |
| 700 | 1 | |a Micheau, Marguerite |e investigator |4 oth | |
| 700 | 1 | |a Ryman, Anne |e investigator |4 oth | |
| 700 | 1 | |a Chambost, Hérve |e investigator |4 oth | |
| 700 | 1 | |a Falaise, Céline |e investigator |4 oth | |
| 700 | 1 | |a Claeyssens, Ségolène |e investigator |4 oth | |
| 700 | 1 | |a Thiercelin-Legrand, Marie Françoise |e investigator |4 oth | |
| 700 | 1 | |a Fiks-Sigaud, Marianne |e investigator |4 oth | |
| 700 | 1 | |a Fouassier, Marc |e investigator |4 oth | |
| 700 | 1 | |a Fressinaud, Edith |e investigator |4 oth | |
| 700 | 1 | |a Trossaert, Marc |e investigator |4 oth | |
| 700 | 1 | |a Voisin, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Faradji, Albert |e investigator |4 oth | |
| 700 | 1 | |a Lutz, Patrick |e investigator |4 oth | |
| 700 | 1 | |a Briquel, Marie Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Frotscher, Birgit |e investigator |4 oth | |
| 700 | 1 | |a Fimbel, Béatrice |e investigator |4 oth | |
| 700 | 1 | |a Gruel, Yves |e investigator |4 oth | |
| 700 | 1 | |a Guerois, Claude |e investigator |4 oth | |
| 700 | 1 | |a Regina, Sandra |e investigator |4 oth | |
| 700 | 1 | |a Valentin, Jean Baptiste |e investigator |4 oth | |
| 700 | 1 | |a Biron Andreani, Christine |e investigator |4 oth | |
| 700 | 1 | |a Codine, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Donadio, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Navarro, Robert |e investigator |4 oth | |
| 700 | 1 | |a Rospide, Paola |e investigator |4 oth | |
| 700 | 1 | |a Schved, Jean-François |e investigator |4 oth | |
| 700 | 1 | |a Berger, Claire |e investigator |4 oth | |
| 700 | 1 | |a Collet, Bénédicte |e investigator |4 oth | |
| 700 | 1 | |a Derlon, Annie Borel |e investigator |4 oth | |
| 700 | 1 | |a Gautier, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Bayart, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Guillet, Ben It |e investigator |4 oth | |
| 700 | 1 | |a Borg, JeanneYvonne |e investigator |4 oth | |
| 700 | 1 | |a Dumesnil, Cécile |e investigator |4 oth | |
| 700 | 1 | |a Normand, Charline |e investigator |4 oth | |
| 700 | 1 | |a Schneider, Pascale |e investigator |4 oth | |
| 700 | 1 | |a Tron, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Vannier, Jean-Pierre |e investigator |4 oth | |
| 700 | 1 | |a Dutrillaux, Fabienne |e investigator |4 oth | |
| 700 | 1 | |a Volot, Fabienne |e investigator |4 oth | |
| 700 | 1 | |a Gembara, Piotr |e investigator |4 oth | |
| 700 | 1 | |a Marques-Verdier, Alain |e investigator |4 oth | |
| 700 | 1 | |a Adjaoud, Dalila |e investigator |4 oth | |
| 700 | 1 | |a Barro, Claire |e investigator |4 oth | |
| 700 | 1 | |a Pernod, Gilles |e investigator |4 oth | |
| 700 | 1 | |a Polack, Ben It |e investigator |4 oth | |
| 700 | 1 | |a Pouzol, Patricia |e investigator |4 oth | |
| 700 | 1 | |a Ounnoughene, Nadra |e investigator |4 oth | |
| 700 | 1 | |a Paugy, Patricia |e investigator |4 oth | |
| 700 | 1 | |a Robert, Valérie |e investigator |4 oth | |
| 700 | 1 | |a Stieltjes, Natalie |e investigator |4 oth | |
| 700 | 1 | |a Bastenaire, Brigitte |e investigator |4 oth | |
| 700 | 1 | |a de Raucourt, Emmanuelle |e investigator |4 oth | |
| 700 | 1 | |a Peynet, Jocelyne |e investigator |4 oth | |
| 700 | 1 | |a Rafowicz, Anne |e investigator |4 oth | |
| 700 | 1 | |a Li-Thiao-Te, Valérie |e investigator |4 oth | |
| 700 | 1 | |a Pautard, Brigitte |e investigator |4 oth | |
| 700 | 1 | |a Behar, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Gorde, Stéphanie |e investigator |4 oth | |
| 700 | 1 | |a Munzer, Martine |e investigator |4 oth | |
| 700 | 1 | |a Gay, Valérie |e investigator |4 oth | |
| 700 | 1 | |a Benz Lemoine, Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Macchi, Laurent |e investigator |4 oth | |
| 700 | 1 | |a De Lumley, Lionel |e investigator |4 oth | |
| 700 | 1 | |a Gaillard, Solange |e investigator |4 oth | |
| 700 | 1 | |a Oudot, Caroline |e investigator |4 oth | |
| 700 | 1 | |a Deville, Anne |e investigator |4 oth | |
| 700 | 1 | |a Monpoux, Fabrice |e investigator |4 oth | |
| 700 | 1 | |a Bertrand, Marie Anne |e investigator |4 oth | |
| 700 | 1 | |a Pan-Petesch, Brigitte |e investigator |4 oth | |
| 700 | 1 | |a Hassoun, Abel |e investigator |4 oth | |
| 700 | 1 | |a Coatmelec, Brigitte |e investigator |4 oth | |
| 700 | 1 | |a Beurrier, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Damay, Michèle |e investigator |4 oth | |
| 700 | 1 | |a Moreau, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Pouille-Lievin, Odile |e investigator |4 oth | |
| 700 | 1 | |a Schoepfer, Caroline |e investigator |4 oth | |
| 700 | 1 | |a Tarral, Eliane |e investigator |4 oth | |
| 700 | 1 | |a Bianchin, Monique |e investigator |4 oth | |
| 700 | 1 | |a Nguyen, Joël |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of pediatrics |d 1945 |g 234(2021) vom: 05. Juli, Seite 212-219.e3 |w (DE-627)NLM000019003 |x 1097-6833 |7 nnns |
| 773 | 1 | 8 | |g volume:234 |g year:2021 |g day:05 |g month:07 |g pages:212-219.e3 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jpeds.2021.02.071 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 234 |j 2021 |b 05 |c 07 |h 212-219.e3 | ||